Predictive Oncology Inc.
- POAI
- NASDAQ
- Medical - Instruments & Supplies
- AI-Driven Precision Oncology
- Cancer Drug Discovery
$4.91
Today +6.28%Quote Apr 21, 2026, 07:59 PM UTC
+29.64%over the last month
Max drawdown −46.5%From 1-month high −46.5%3 months +91.8%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About Predictive Oncology
Predictive Oncology Inc. (POAI), an organization driven by expertise and data, is dedicated to pioneering individualized cancer treatments through the application of artificial intelligence, primarily within the United States. The company conducts its operations across four distinct divisions: Helomics, zPREDICTA, Soluble, and Skyline.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Exchange
NASDAQ
Employees
23
Founded
2002
Market value
$96.7M
Approximate share count
Floor
$4.47
9.0% below price
Resistance
$5.16
5.1% above price
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about POAIPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free